JPMorgan keeps Merit Medical Systems at Overweight and lifts target to $110
JPMorgan kept its Overweight rating on Merit Medical Systems and raised its price target from $95 to $110. TradingView reports the move equals a 15.8% increase.
- published on Newsmetry
- original source published
the same feed is available to bots and dashboards through the api. connect the api →
what happened
According to TradingView, JPMorgan kept its Overweight rating on Merit Medical Systems shares and raised its price target to $110 from $95, a rise of 15.8%. The new target points to 27.6% upside from the October 30 close of $86.24.
Four analyst notes on the company were published over the past 30 days. Wells Fargo kept an Equal-Weight rating with a $92 target, Needham holds Buy at $106, BTIG also has Buy but at $110, and Freedom Capital Markets began coverage on October 27 with an On Hold rating and a $90 target. Targets across these notes range from $90 to $110.
why it matters
Routine updates like this rarely move the broader market, but they show how professional analysts view the company at a given moment. Investors often compare such opinions with quarterly results and the company's own guidance.
tags
instruments
sources
- JP Morgan maintains Merit Medical Systems at Overweight, raises price target to $110 from $95 — TradingView, 30 October 2026 at 22:49 UTC
prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.
alerts on your topics, the morning digest and the api — in your account.
get stories in real time ↗